Michael Choukas is Chief Executive Officer of Vector Oncology, a leader in the design and delivery of care based, real world oncology research and data analytics. Prior to joining Vector Oncology, he served as Operating Partner of The Watermill Group.
Previously, Mike served as President and CEO of Oncopartners, a Latin American oncology development services company, which he founded in 2006. Prior to his work with Oncopartners, he was a member of the leadership team of United Biosource Corporation (UBC) where he served as Executive Vice President of Strategy and Operations and Executive Chairman of the Late Stage Group from 2004 to 2006. In 1996, Mike founded SCIREX Corporation and served as Chairman and CEO until 2003. He held senior leadership positions as Chairman and CEO of Springborn Laboratories, Executive Vice President of Dun and Bradstreet Software and Services, and as a Partner at Bain & Company, where he contributed to the leadership of Bain’s software and M&A practice areas. Mike began his career serving on the staff of the US Senate Committee on Environment and Public Works and then as Legislative Director for US Senator Patrick Leahy.
Mike currently serves as Chairman of the Board of Trustees for Vermont Academy, and as an Advisor to the Watermill Group. He holds an MBA from Harvard University and a BA in Economics from Dartmouth College.